Podcasts about cardiac

In this powerful episode, I sit down with Dr. Jeremy London—a board-certified cardiothoracic surgeon with over 26 years of experience—to uncover the often-overlooked truths about cardiovascular disease, especially in women. Dr. London shares why menopausal women face triple the risk for heart disease, and what you can do to protect yourself. From the life-saving power of simply moving your body to the three essential tests everyone should be asking for, this conversation breaks down complex health topics into clear, actionable steps. Whether you're navigating midlife or looking to take preventative measures, this episode is a must-listen for anyone ready to take control of their heart health. About Dr. Jeremy London: Dr. Jeremy London is a Board-Certified Cardiothoracic Surgeon with over 26 years of clinical experience. He earned his medical degree from the Medical College of Georgia and completed his surgical training in Denver and Charlotte. A passionate advocate for patient education, Dr. London is on a mission to make health information more accessible through his newsletter, podcast, and social media. He lives in Savannah, Georgia with his wife and their three sons. *** Subscribe to The Neuro Experience for more conversations at the intersection of brain science and performance. I'm committed to bringing you evidence-based insights that you can apply to your own health journey. *** A huge thank you to my sponsors for supporting this episode. Check them out and enjoy exclusive discounts: Caraway: www.caraway.com/neuro for an additional 10% off your purchase LMNT: Use code drinklmnt.com/neuro to get a free 8-count Sample Pack of LMNT's most popular drink mix flavors with any purchase. MUDWTR - The coffee alternative. If you're ready to ditch the crash and sip smarter, go to mudwtr.com and use code NEURO to get 43% off + free shipping. David's Protein: Buy four cartons and get your fifth one completely free | Head to www.davidprotein.com/neuro Branch Basics: www.branchbasics.com to shop their Premium Starter Kit and save 15% | Code: NEURO *** Topics discussed: 00:00:00: Why women's cardiovascular risk triples after menopause 00:03:40: Two out of three Alzheimer's disease patients are women 00:04:47: What are lipid panels 00:05:20: Cardiovascular disease is the number one cause of death worldwide 00:06:13: The three buckets of heart disease 00:07:27: Cholesterol  00:08:47: ApoB 00:10:15: Plaque 00:10:53: Lp(a) 00:14:39: Louisa's mother's lab results 00:16:09: Going beyond lab work: Screen tests 00:17:39: Cardiac catheterization  00:19:49: Carotid ultrasound  00:21:07: What is atrial fibrillation and how is it diagnosed? 00:26:37: What you can do yourself to diagnose Afib 00:31:14: What was COVID like in the cardiovascular department? 00:35:47: Blood pressure 00:41:48: AI in the medical field 00:48:07: Exercise to minimize risk of cardiovascular disease 00:53:21: Healthy nutrition to minimize risk of cardiovascular disease 00:55:01: Can supplement eliminate plaque? 00:56:09: Changing our lifestyle and diet to mitigate diseases 00:57:31: Sleep quality to minimize risk of cardiovascular disease *** I'm Louisa Nicola — clinical neuroscientist — Alzheimer's prevention specialist — founder of Neuro Athletics. My mission is to translate cutting-edge neuroscience into actionable strategies for cognitive longevity, peak performance, and brain disease prevention. If you're committed to optimizing your brain — reducing Alzheimer's risk — and staying mentally sharp for life, you're in the right place. Stay sharp. Stay informed. Join thousands who subscribe to the Neuro Athletics Newsletter → https://bit.ly/3ewI5P0 Instagram: https://www.instagram.com/louisanicola_/ Twitter : https://twitter.com/louisanicola_

This is the noon All Local for Thursday, July 24, 2025

College Tennis Player COLLAPSES! DIES SUDDENLY from "CARDIAC EVENT" during Half Marathon!

Listener discretion is advised. Reference: Tsukube, T., Okita, Y. (2017). Cardiac tamponade due to aortic dissection: clinical picture and treatment with focus on pericardiocentesis. E-Journal of Cardiology Practice. European Society of Cardiology. Available: https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-15/Cardiac-tamponade-due-to-aortic-dissection-clinical-picture-and-treatment-with-focus-on-pericardiocentesis

Kavus Torabi in conversation with David Eastaugh https://kavustorabi.bandcamp.com/album/the-banishing https://www.planetgong.co.uk/ https://theutopiastrong.bandcamp.com/album/the-utopia-strong Musician, composer, record label owner and radio broadcaster. A multi-instrumentalist, he is known for his work in the psychedelic, avant-garde rock field (primarily as a guitarist). Torabi was one of the founding members of the Monsoon Bassoon (as singer, guitarist and one of the two primary composers), was a member of the cult rock band Cardiacs, and fronts and plays guitar for the current lineup of legendary psychedelic band Gong. Torabi also leads his own group Knifeworld and is a member of Guapo and the Utopia Strong.  

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Baseline Cardiac Biomarker Levels as Predictors of Cancer Risk in the MESA Cohort.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Raising the Alarm: Underdiagnosis of Cardiac Sarcoidosis in Young Patients With Unexplained Heart Block.

Cardiac arrest in the operating room presents unique challenges that standard Advanced Cardiovascular Life Support (ACLS) protocols simply were not designed to address. This eye-opening exploration with APSF author, Zachary Smith, reveals why traditional resuscitation guidelines fall short when emergencies strike during surgery and anesthesia care.The dynamics of cardiac arrest differ dramatically in the perioperative environment. While out-of-hospital arrests typically stem from arrhythmic events, OR emergencies often result from hemorrhage, embolism, hypoxemia, or critical drug reactions like malignant hyperthermia or local anesthetic toxicity. These scenarios demand immediate, specialized interventions beyond standard ACLS algorithms.Physical constraints further complicate matters. What happens when cardiac arrest occurs while a patient is positioned prone, lateral, or in steep Trendelenburg? Traditional compressions become impossible, and emerging research suggests prone CPR might actually be superior in some scenarios. Moreover, the advanced monitoring capabilities in the OR – arterial lines, central venous pressure readings, and echocardiography – provide critical data not incorporated into standard protocols.The American Society of Anesthesiologists has responded with their Perioperative Resuscitation and Life Support Certificate program, addressing these gaps through specialized training that combines ACLS principles with OR-specific knowledge.  Ready to enhance your skills beyond basic ACLS? Explore the ASA's certificate program to earn patient safety CME credits while gaining life-saving expertise tailored to the unique challenges of the operating room. Your specialized knowledge could make all the difference when seconds count.For show notes & transcript, visit our episode page at apsf.org: https://www.apsf.org/podcast/264-rethinking-resuscitation-in-the-operating-room-beyond-acls/© 2025, The Anesthesia Patient Safety Foundation

Cardiac electrophysiology is rapidly evolving, blending procedural expertise with innovations in pharmacotherapy, device design, and lifestyle medicine. This week's Editor's Page spotlights key studies from JACC that challenge long-standing practices—from lifestyle strategies for atrial fibrillation to the role of defibrillation testing and device comparisons. We also explore disparities in cardiac arrest outcomes and complex real-world cases that push clinical boundaries. Tune in for a dynamic look at the future of arrhythmia care.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete NCPD information, and to apply for credit, please visit us at PeerView.com/HXH865. NCPD credit will be available until July 12, 2026.Nursing Strategies in Transthyretin Cardiac Amyloidosis: Targeted Therapies and the Patient Experience In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Alnylam Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete NCPD information, and to apply for credit, please visit us at PeerView.com/HXH865. NCPD credit will be available until July 12, 2026.Nursing Strategies in Transthyretin Cardiac Amyloidosis: Targeted Therapies and the Patient Experience In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Alnylam Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete NCPD information, and to apply for credit, please visit us at PeerView.com/HXH865. NCPD credit will be available until July 12, 2026.Nursing Strategies in Transthyretin Cardiac Amyloidosis: Targeted Therapies and the Patient Experience In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Alnylam Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete NCPD information, and to apply for credit, please visit us at PeerView.com/HXH865. NCPD credit will be available until July 12, 2026.Nursing Strategies in Transthyretin Cardiac Amyloidosis: Targeted Therapies and the Patient Experience In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Alnylam Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

Guest: Parul Rai Cardiopulmonary complications are a leading cause of early mortality in adults with sickle cell disease, with evidence showing that cardiac injury may begin as early as childhood. However, despite the severity of these issues, there are currently no uniform guidelines for asymptomatic cardiac screening in this population. Join Dr. Parul Rai, a physician in the Department of Hematology at St. Jude's Hospital in Memphis, Tennessee, to learn about current research, early detection strategies, and the need for more sensitive diagnostic markers to prevent severe cardiac outcomes in patients with sickle cell disease.

This episode covers: Cardiology This Week: A concise summary of recent studies ICD Indications in primary prevention Drug treatment of cardiac amyloidosis Mythbusters Host: Rick Grobbee Guests: Carlos Aguiar, Gerhard Hindricks, Marianna Fontana Want to watch that episode? Go to: https://esc365.escardio.org/event/1810   Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors.  This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. The ESC is not liable for any translated content of this video. The English-language always prevails. Declarations of interests: Stephan Achenbach, Rick Grobbee, Gerhard Hindricks and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Marianna Fontana has declared to have potential conflicts of interest to report: consultancy for Alnylam, Alexion/Caelum Biosciences, Astrazeneca, Bridgbio/Eidos, Prothena, Attralus, Intellia Therapeutics, Ionis Pharmaceuticals, Cardior, Lexeo Therapeutics, Janssen Pharmaceuticals, Prothena, Pfizer, Novonordisk, Bayer, Mycardium. Research grants from: Alnylam, Bridgbio, Astrazeneca, Pfizer. Share options in LexeoTherapeutics and shares in Mycardium. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

In this episode of Everyday Health Stories, Dr. Reddy and Anna dive into the fascinating and often overlooked connection between heart health and brain function. Through real-life patient cases and cutting-edge science, they explore how conditions like atrial fibrillation, high blood pressure, and sleep apnea can silently impact memory, cognition, and overall brain performance. The discussion highlights emerging diagnostic tools—like Cardiac and Brain PET scans—that can detect early signs of microvascular disease, a shared root cause of both heart disease and cognitive decline. Listeners will also hear exciting news about how these advanced scans will soon be available at Dr. Reddy's clinic, offering hope for earlier detection and prevention. With practical tips and powerful insights, this episode empowers listeners to protect both their heart and mind—because when one thrives, the other often does too.

Cardiac electrophysiologist Seth Goldbarg, MD, shares how AI can improve outcomes for patients with persistent and longstanding atrial fibrillation by identifying critical areas for ablation. Let us know what you thought of this week's episode on Twitter: @physicianswkly Want to share your medical expertise, research, or unique experience in medicine on the PW podcast? Email us at editorial@physweekly.com! Thanks for listening!

On this episode of Good Day Health, host Doug Stephan and Dr. Ken Kronhaus of Lake Cardiology (352-735-1400) dive into this week's top health stories and answer listener questions with expert insights. First up: AI in medicine. Dr. Ken shares how he prefers to think of artificial intelligence as “Assisted Intelligence,” explaining how new technologies are enhancing diagnostics and patient care. One example? Advanced AI models can now analyze heart MRIs and medical records to detect subtle scar patterns that predict sudden cardiac death — a game-changer in preventive cardiology. Speaking of prevention, Dr. Ken emphasizes a growing “fourth pillar” in the fight against heart disease: vaccinations for common infections, joining the ranks of diet, exercise, and medication. Then, Doug shares a wild personal story: after days of ear pain and a misdiagnosis of infection, the true culprit was revealed — a ladybug stuck in his ear. This leads into a broader discussion on ear health and new research showing that wearing hearing aids may actually improve your social life. Also on the brain: New research finds that the human hippocampus — the brain's memory center — continues generating new neurons even in old age, offering new hope for cognitive longevity. Listener questions include:Is Semaglutide (Ozempic, Wegovy) offering more than weight loss benefits, such as protecting limbs in patients with Type 2 diabetes?What's up with the new COVID-19 variant XFG (“Stratus”) and its unusual symptom — a raspy voice?Join Doug and Dr. Ken for a fast-paced, informative hour packed with useful health tips, surprising discoveries, and practical advice for everyday wellness.Webstie: GoodDayHealthShow.comSocial Media: @GoodDayNetworks

If you're an injured runner we can help you get back to running pain-free.Click the link to book a free call with ushttps://matthewboydphysio.com/booking/Running Fundamentals Coursehttps://matthewboydphysio.com/running-fundamentals-course/Instagramhttps://www.instagram.com/matthewboydphysio/SummaryThis episode delves into the significance of VO2 max for endurance runners, explaining its role in enhancing running performance. Matthew Boyd discusses how improving VO2 max can elevate overall running capabilities, the physiological adaptations that occur through targeted training, and the strategic implementation of VO2 max intervals to maximize performance gains. The discussion emphasizes the importance of structured training and the potential benefits of working with a coach to optimize training plans.TakeawaysVO2 max is crucial for endurance runners.Improving VO2 max raises the ceiling on running performance.Interval training is an effective method to enhance VO2 max.Higher VO2 max allows for better oxygen utilization.Cardiac output and mitochondrial efficiency are key adaptations.Strategic training is essential for long-distance runners.VO2 max intervals should be incorporated at specific times.Testing VO2 max pace helps track progress.Accumulating time at VO2 max is vital for improvement.Coaching can help implement effective training strategies.

With Francesca Coraducci Marche Polytechnic University of Ancona, Ancona - Italy, Marco Guglielmo, University Medical Center Utrecht, Utrecht - The Netherlands, and Anna Giulia Pavon, Cardiocentro Ticino Institute, Lugano - Switzerland. Link to editorial Link to paper

What if everything you thought you knew about weight, fat, and heart health was wrong?Join us as we sit down with world-renowned cardiologist Dr. Carl Chip Lavie, author of The Obesity Paradox, to explore why fitness may be a stronger predictor of health than weight itself.From the surprising data behind VO2 Max and body fat to the hidden dangers of sitting too long, this conversation will challenge conventional wisdom and give you science-backed strategies to live longer, healthier, and stronger.

7/10/2025 | Cardiac

7/10/2025 | Cardiac

In this high-elevation episode of Strength In Knowledge, we explore how to optimize endurance performance when the air gets thin. Based on the research by Salgado, Ryan, Seeley, and Charkoudian, we dive into both traditional and cutting-edge strategies designed to help athletes thrive at altitude.From acclimatization protocols and hypoxic training to novel interventions like dietary supplements and advanced breathing techniques, this episode examines what the science says—and what actually works. Whether you're coaching endurance athletes, treating altitude-related fatigue, or training for your own alpine challenge, you'll gain valuable insights into boosting performance when oxygen is limited.⛰️ Tune in to learn how to go further, faster, and stronger—no matter the altitude.Improving Endurance Exercise Performance at High Altitude: Traditional and Nontraditional Approaches Salgado, Roy M.; Ryan, Benjamin J.; Seeley, Afton D.; Charkoudian, Nisha DOI: 10.1249/JES.0000000000000347

As cardiac rehab evolves, innovative care models are key to better outcomes and financial sustainability. In this special episode of HeartTalk, vice presidents of Care Transformation Services at MedAxiom, Denise Busman, MSN, RN, CPHQ, FACC, and Jenny Kennedy, DNP, RN, CHFN, NEA-BC, FACC sit down with Sarah Shelton, cardiac rehabilitation manager and Rod Roeser, CEO at Heart and Vascular Care (HVC). They discuss how they successfully implemented Intensive Cardiac Rehab (ICR), including their strategies to overcome space and staffing challenges, boost provider and patient engagement, and scale ICR programs for clinical, operational, and financial success.

In this eye-opening episode of the Whole Body Detox Show, discover the shocking truth behind the widespread use of cardiac procedures like stents (PCI) and bypass surgery (CABG) — and why many may be unnecessary for those with stable heart disease.Drawing insights from Dr. Brownstein's Natural Way to Health and years of clinical experience, host David DeHaas of Living Waters Wellness Center breaks down how the medical industry often prioritizes profit over patient well-being, leaving many uninformed about the actual risks, benefits, and alternatives to invasive procedures.

In this insightful episode of Parallax, Dr Ankur Kalra explores the emerging field of cardiac epigenetics with Dr Manuel Rosa-Garrido, assistant professor of medicine at the University of Alabama in Birmingham. Their conversation examines how the three-dimensional organization of DNA within the cell nucleus influences heart disease development beyond traditional genetic sequencing. Dr Rosa-Garrido shares his pioneering work using Hi-C technology to map genome structure, revealing that DNA arrangement plays a crucial role in cardiac pathology. The discussion covers key concepts including chromatin loops, topologically associating domains, and compartmentalization—explaining how these structures regulate gene expression and how their disruption contributes to cardiovascular disease. The episode explores practical implications for clinical practice, from early biomarker identification to potential CRISPR-based therapies that could target chromatin structure. Dr Rosa-Garrido outlines how this research could transform cardiovascular care within the next decade, offering new approaches to both inherited cardiomyopathies and environmentally-influenced conditions like atherosclerosis. Valuable insights for cardiologists interested in precision medicine and the evolving understanding of how genetic architecture influences cardiovascular risk and treatment strategies. Questions and comments can be sent to "podcast@radcliffe-group.com" and may be answered by Ankur in the next episode. Host: @AnkurKalraMD and produced by: @RadcliffeCardio Parallax is Ranked in the Top 100 Health Science Podcasts (#48) by Million Podcasts.

In this episode of JACC This Week, Editor-in-Chief Dr. Harlan Krumholz summarizes key studies from the July 15 issue, focused on cardiovascular interventions. Topics include new insights on plaque vulnerability in acute coronary syndromes, virtual flow reserve after PCI, long-term data on FFR-guided revascularization, and stent thrombosis risk. This issue delivers high-impact, practice-relevant research for interventionalists, imaging specialists, and general cardiologists alike.

Content managed by ContentSafe.coSupport the show

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. Welcome to diabetes core update where every month we go over the most important articles to come out in the field of diabetes. Articles that are important for practicing clinicians to understand to stay up with the rapid changes in the field.  This issue will review: 1.    Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes 2.    Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension Meta-Analysis 3.    The Diabetes Prevention Program and Its Outcomes Study: NIDDK's Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact 4.    Comparative effectiveness of alternative second‐line oral glucose‐lowering therapies for type 2 diabetes: a precision medicine approach applied to routine data 5.    Phase 3 Trial of Semaglutide in Metabolic Dysfunction– Associated Steatohepatitis   For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

Commentary by Dr. Jian'an Wang.

Message our hosts, Kieran and Jose.Season 3 of The Animal Heartbeat is all about the Veterinary Cardiology Icons - those who walk among us as legends of the veterinary cardiology world.This episode features Professor Sydney Möise, of Cornell University, CV Starr Professor Emerita of Cardiology. Prof Möise's research and education output on cardiac arrhythmias has shaped how many of us think about electrical problems of the heart, and she has become known as a pioneer of ambulatory ECG assessment of heart rate variability. Her recent collaborations with Wyatt Flanders, her son, has given the veterinary cardiology world free access to dynamic and 3D Poincaré plots in dogs, broadening our understanding of conduction system disease in animals.Join our hosts, Kieran and Jose, as they discuss canine cardiac arrhythmias with a legend in their field.

Pete Hegseth decimates fake news about the Iran strikes at a press conference Thursday morning. DNI Tulsi Gabbard has reportedly been sidelined from briefings to Congress over the success of the strikes. A “Cobra Kai” actor confronts co-star Martin Kove over biting her on set. Jamaal Bowman says black people suffer from heart disease and obesity because they carry the stress of being called the ‘N' word every day. Eric Adams plans to run as an independent, which will make Zohran Mamdani the next Mayor of New York City. Dana still can't believe Andrew Cuomo ran for mayor. Jasmine Crockett mocks Melania Trump's visa and modeling career during a Congressional hearing. Rep. Jayapal accidentally tweets absolute falsehoods about a pregnant woman being detained by ICE. Texans are turning on Lt. Gov. Dan Patrick over his stance banning THC.Thank you for supporting our sponsors that make The Dana Show possible…Relief Factorhttps://ReliefFactor.com OR CALL 1-800-4-RELIEFTurn the clock back on pain with Relief Factor. Get their 3-week Relief Factor Quick Start for only $19.95 today! Goldcohttps://DanaLikesGold.com Protect your financial future with my trusted gold company—get your GoldCo 2025 Gold & Silver Kit today, and you could qualify for up to 10% in bonus silverByrnahttps://byrna.com/danaGet your hands on the new compact Byrna CL. Visit Byrna.com/Dana receive 10% off Patriot Mobilehttps://PatriotMobile.com/DanaVeterans, Active Duty Military & First Responders get 15% OFF monthly. PLUS get a FREE MONTH of service code DANAHumanNhttps://humann.comFind both the new SuperBerine and the #1 bestselling SuperBeets Heart Chews at Sam's Club!KelTechttps://KelTecWeapons.comSee the third generation of the iconic SUB2000 and the NEW PS57 - KelTec Innovation & Performance at its bestAll Family Pharmacyhttps://AllFamilyPharmacy.com/DanaCode Dana20 for 20% off your entire orderPreBornhttps://Preborn.com/DanaWith your help, we can hit the goal of 1,000 ultrasounds by the end of June! Just dial #250 and say “Baby”

This week, Dr. Kahn discussed two patients at the Kahn Center who were referred for cardiac bypass surgery (CABG) but have chosen to pursue a science-backed, yet rigorous, program of lifestyle and medication. Dr. Kahn discussed the new CENTURY study, which demonstrated that "comprehensive" care over five years in heart patients significantly improved outcomes and helped avoid CABG. Dr. Kahn goes on to review shorter topics including a new video by Valter Longo, Ph.D. (WATCH HERE), conflicts in research on meat, outcomes on statin Rx medications, black vs. sweet coffee, low-fiber and red meat diets on heart plaque, and the Sit-to-Stand test.  Thanks to igennus.com and the discount code DRKAHN.

With Frank Flachskampf, Uppsala University, Uppsala - Sweden, and James Thomas, Northwestern University, Chicago - USA.  Link to editorial  Link to paper  

This week we speak with Professor Vladimiro Vida of U. Padua about a recent ECHSA large scale study assessing surgical outcomes of newborn cardiac surgery in Europe. What trends have become apparent in the past 10 years and why are outcomes generally better overall in this complex patient group? Why have outcomes for single ventricle surgery not improved as much as other newborn surgeries? Is there a relationship between center volume and outcomes? What interventions might result in improvements in outcomes of Norwood palliation? Dr. Vida provides his insights this week. https://doi.org/10.1016/j.athoracsur.2024.07.023

When blood, or other fluids, accumulate in the sac around the heart it's called a cardiac tamponade or pericardial tamponade.The effects of tamponade on the electrical system and chambers of the heart.Cardiac tamponade can be acute or chronic and caused by traumatic, iatrogenic, or pathological etiologies.Common traumatic events, medical procedures, and diseases that can result in a pericardial tamponade. Signs & symptoms of cardiac tamponade.Treatment of cardiac tamponade with pericardiocentesis.For additional information on cardiac tamponade, check out the Pod Resources page at PassACLS.com. Good luck with your ACLS class!Links: Buy Me a Coffee at https://buymeacoffee.com/paultaylor Practice ECG rhythms at Dialed Medics - https://dialedmedics.com/Free Prescription Discount Card - Download your free drug discount card to save money on prescription medications for you and your pets: https://safemeds.vipPass ACLS Web Site - Episode archives & other ACLS-related podcasts: https://passacls.com@Pass-ACLS-Podcast on LinkedIn

This global, multicenter registry included 2,579 CRT recipients with LVEF ≤ 50% who underwent either LBBAP or conventional biventricular pacing (BVP), with 780 matched pairs analyzed. Over a mean follow-up of 34 ± 15 months, LBBAP significantly reduced the combined endpoint of all-cause death or first heart failure hospitalization (22.2% vs 30.8%; HR 0.81; P≈0.048), largely driven by fewer HF hospitalizations (13.6% vs 20.8%; HR 0.63; P

Welcome back, gas passers! It's time to pick up right where we left off—because your heart (and your patients') can't afford to miss part two of our special cardiac anesthesia series on the North American Veterinary Anesthesia Society Podcast! Host Dr. Bonnie Gatson returns with the fabulous Dr. Carolyn McKune of Mythos Veterinary LLC to continue our journey into the nuanced world of anesthetizing dogs and cats with cardiac disease. Now that we've covered the pathophysiology and prep in our first episode, it's time to talk protocols: how do we tailor anesthetic plans for patients with mitral valve disease and hypertrophic cardiomyopathy? What intraoperative monitoring really matters? And how do we handle those dreaded hypotensive or arrhythmogenic moments? This episode is guaranteed to provide some heartfelt guidance on tackling anesthetic management for these commonly seen, but nevertheless challenging patients.If you like what you hear, we have a couple of favors to ask of you:Become a member of NAVAS for access to more anesthesia and analgesia educational and RACE-approved CE content. Register for the Live Online Fireside Chat #16 - Non-Invasive Blood Pressure: To Trust or Not To Trust. FREE for NAVAS members happening on Wednesday, June 18th at 7pm EST. The North American Veterinary Anesthesia Society (NAVAS) helps veterinary professionals and caregivers advance and improve the safe administration of anesthesia and analgesia to all animals, through development of standards consistent with recent findings documented in high quality basic and clinical scientific publications and texts.Spread the word. Share our podcast on your socials or a discussion forum. That would really help us achieve our mission: Reduce mortality and morbidity in veterinary patients undergoing sedation, anesthesia, and analgesia through high-quality, peer-reviewed education.Thank you to our sponsor, Dechra - learn more about the pharmaceutical products Dechra has to offer veterinary professionals, such as Zenalpha.If you have questions about this episode or want to suggest topics for future episodes, reach out to the producers at education@mynavas.org.All opinions stated by the host and their guests are theirs alone and do not represent the thoughts or opinions of any corporation, university, or other business or governmental entity.

Today, we're diving into a critical topic in modern healthcare: the perioperative management of patients with implanted electronic devices undergoing noncardiac surgery. With significant advancements in cardiology and cardiothoracic surgery, cardiac implantable electronic devices (CIEDs), including pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy devices, are becoming increasingly common in the surgical population. From pre-op assessment and EMI planning to post-op reprogramming, this deep dive breaks down complex protocols into actionable, life-saving steps. Here's some of what we discuss in this episode:

Why Pulmonary Hypertension Isn't Just a Lung ProblemCardiologist Dr. Lisa Mielniczuk from the Mayo Clinic pulls back the curtain on one of the most common — yet misunderstood — forms of pulmonary hypertension: the kind caused by left heart disease. In this episode, she explains why it's time we stop thinking of PH as a rare condition. Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Follow us on social @phaware Engage for a cure: www.phaware.global/donate #phaware Share your story: info@phaware.com @phacanada  #phawareMD @mayoclinic @teamphhope

In this episode, Dr. Valentin Fuster discusses a study showing that elevated cardiac troponin levels after intense exercise in middle-aged recreational athletes are common but not linked to hidden coronary artery disease. The findings raise important questions about the origin and significance of these elevations, highlighting the need for long-term follow-up.

In this 310th episode I welcome Dr. Annemarie Thompson, head of the working group that put out the new AHA/ACC Guidelines for the perioperative cardiovascular management for noncardiac surgery, and Drs. Jochen Steppan and Giancarlo Suffredini, cardiac anesthesiologists, to talk about the new iteration of the guidelines. We go through the algorithm in detail and talk about the evidence behind it and how to use biomarkers. Our Sponsors:* Check out Eko: https://ekohealth.com/ACCRAC* Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com* Check out Factor: https://factormeals.com/accrac50off* Check out Truelearn and use my code ACCRAC for a great deal: https://truelearn.comAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Justin Bourne and Sam McKee look back on the Edmonton Oilers' 5-4 comeback win over the Florida Panthers in Game 4 to tie up the Stanley Cup Final. The Athletic's Shayna Goldman (8:30) shares her take on Game 4 and digs in on the Oilers' resilience, the Panthers' collapse, why Edmonton needs to stick with Calvin Pickard for Game 5, the importance of blueline production and Sam Bennett's open-market value. Then, Justin and Sam react to reports that Mitch Marner will not return to Toronto next season and project where he might land in free agency. They close out the week by answering your questions on the text line!The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of Rogers Sports & Media or any affiliates.

Today, we will go over what cardiac tamponade is, how it results, and most importantly, how we diagnose and treat it. After listening to this podcast, you will be able to: 1. Define cardiac tamponade and explain its pathophysiology. 2. Describe the boundaries of the cardiac box and list the elements of Beck's triad. 3. Identify the key clinical features of cardiac tamponade and explain how to make the diagnosis. 4. Discuss the management of cardiac tamponade, including emergent interventions and definitive treatment strategies.

Beyond the Clinical Trial: What Real-World Data Means for You Think only people in clinical trials help advance medicine? Think again. Dr. Jason Weatherald explains how your everyday clinic visits — from walk tests to how you feel — can help shape the future of pulmonary hypertension treatment. Learn what "real-world evidence" is and why your story matters more than you think. Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Follow us on social @phaware Engage for a cure: www.phaware.global/donate #phaware Share your story: info@phaware.com @phacanada  #phawareMD @teamphhope  @AlbertaPHdoc @UAlberta

The chain of survival for ACLS is the same as was learned in your BLS class.The beginning steps of the Cardiac Emergency and Stroke chain of survival.ACLS's timed goals for first medical contact to PCI for STEMI and door-to-needle for ischemic stroke.Characteristics of areas that have significantly better stroke and out-of-hospital cardiac arrest outcomes.Good luck with your ACLS class!Links: Buy Me a Coffee at https://buymeacoffee.com/paultaylor Practice ECG rhythms at Dialed Medics - https://dialedmedics.com/Free Prescription Discount Card - Download your free drug discount card to save money on prescription medications for you and your pets: https://safemeds.vipPass ACLS Web Site - Episode archives & other ACLS-related podcasts: https://passacls.com@Pass-ACLS-Podcast on LinkedIn

Cardiac arrest remains one of the leading causes of death worldwide, striking without warning and demanding urgent emergency response. In this episode of The Health Technology Podcast, we spotlight cardiac arrest prevention, portable defibrillator innovation, and next-generation AED technology featuring Sameer Jafri, CEO and co-founder of Avive Solutions. From his early days volunteering at cardiac screenings to founding a nonprofit focused on heart health at UCLA, Sameer's dedication to life-saving innovation has always been personal. With Avive Solutions, he is pioneering the development of connected, portable AEDs, making advanced emergency response accessible in homes, schools, sports fields, and public spaces everywhere. Sameer shares how Avive's smart defibrillator ecosystem is changing outcomes by bridging the gap between bystanders and medical professionals. By integrating real-time data and rapid response capabilities, Avive's technology empowers communities to act decisively and improve cardiac arrest survival rates. Whether you're a healthcare innovator, a clinician, or someone passionate about medical technology, this episode reveals what it takes to challenge the status quo in cardiac care. Tune in to hear how Sameer Jafri is transforming the future of emergency medicine through connected devices, better access, and relentless advocacy for cardiac arrest prevention. Do you have thoughts on this episode or ideas for future guests? We'd love to hear from you. Email us at hello@rosenmaninstitute.org.

America Out Loud PULSE with Dr. Mary Talley Bowden – By leveraging advanced mathematical algorithms and artificial intelligence, the MCG detects small vessel disease and ischemia — conditions where tiny heart vessels lack sufficient oxygenation. Identifying early heart disease and potentially preventing heart attacks by addressing small vessel issues before they progress...